Developing a Prediction Model for Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Model Building Approaches

被引:15
作者
Basmadjian, Robert B. [1 ]
Kong, Shiying [1 ,2 ,3 ]
Boyne, Devon J. [1 ,2 ]
Jarada, Tamer N. [2 ]
Xu, Yuan [1 ,2 ,3 ]
Cheung, Winson Y. [1 ,2 ]
Lupichuk, Sasha [1 ,2 ]
Quan, May Lynn [1 ,2 ,3 ]
Brenner, Darren R. [1 ,2 ]
机构
[1] Univ Calgary, Foothills Med Ctr, Dept Community Hlth Sci, Calgary, AB, Canada
[2] Univ Calgary, Tom Baker Canc Ctr, Dept Oncol, Calgary, AB, Canada
[3] Univ Calgary, Foothills Med Ctr, Dept Surg, Calgary, AB, Canada
关键词
SURGICAL ADJUVANT BREAST; NODE-POSITIVE PATIENTS; OPEN-LABEL; THERAPY; TRASTUZUMAB; LAPATINIB; AREAS; TUMOR; INDEX; KI-67;
D O I
10.1200/CCI.21.00055
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE The optimal characteristics among patients with breast cancer to recommend neoadjuvant chemotherapy is an active area of clinical research. We developed and compared several approaches to developing prediction models for pathologic complete response (pCR) among patients with breast cancer in Alberta. METHODS The study included all patients with breast cancer who received neoadjuvant chemotherapy in Alberta between 2012 and 2014 identified from the Alberta Cancer Registry. Patient, tumor, and treatment data were obtained through primary chart review. pCR was defined as no residual invasive tumor at surgical excision in breast or axilla. Two types of prediction models for pCR were built: (1) expert model: variables selected on the basis of oncologists' opinions and (2) data-driven model: variables selected by trained machine. These model types were fit using logistic regression (LR), random forests (RF), and gradient-boosted trees (GBT). We compared the models using area under the receiver operating characteristic curve and integrated calibration index, and internally validated using bootstrap resampling. RESULTS A total of 363 cases were included in the analyses, of which 86 experienced pCR. The RF and GBT fits yielded higher optimism-corrected area under the receiver operating characteristic curves compared with LR for the expert (RF: 0.70; GBT: 0.69; LR: 0.65) and data-driven models (RF: 0.71; GBT: 0.68; LR: 0.64). The LR fit yielded the lowest integrated calibration indices for the expert (LR: 0.037; GBT: 0.05; RF: 0.10) and data-driven models (LR: 0.026; GBT: 0.06; RF: 0.099). CONCLUSION Our models demonstrated predictive ability for pCR using routinely collected clinical and demographic variables. We show that machine learning fit methods can be used to optimize models for pCR prediction. We also show that additional variables beyond clinical expertise do not considerably improve predictive ability and may not be of value on the basis of the burden of data collection.
引用
收藏
页数:10
相关论文
共 47 条
[11]   ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors [J].
Dumont, Aurelie ;
Pannier, Diane ;
Ducoulombier, Agnes ;
Tresch, Emmanuelle ;
Chen, Jinying ;
Kramar, Andrew ;
Revillion, Francoise ;
Peyrat, Jean-Philippe ;
Bonneterre, Jacques .
SPRINGERPLUS, 2015, 4 :1-10
[13]   Neoadjuvant Chemotherapy for Breast Cancer, Is Practice Changing? A Population-Based Review of Current Surgical Trends [J].
Graham, Peter J. ;
Brar, Mantaj S. ;
Foster, Tianne ;
McCall, Mike ;
Bouchard-Fortier, Antoine ;
Temple, Walley ;
Quan, May Lynn .
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (10) :3376-3382
[14]   Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy [J].
Hennessy, BT ;
Hortobagyi, GN ;
Rouzier, R ;
Kuerer, H ;
Sneige, N ;
Buzdar, AU ;
Kau, SW ;
Fornage, B ;
Sahin, A ;
Broglio, K ;
Singletary, SE ;
Valero, V .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9304-9311
[15]   Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer [J].
Heppner, Barbara Ingold ;
Untch, Michael ;
Denkert, Carsten ;
Pfitzner, Berit M. ;
Lederer, Bianca ;
Schmitt, Wolfgang ;
Eidtmann, Holger ;
Fasching, Peter A. ;
Tesch, Hans ;
Solbach, Christine ;
Rezai, Mahdi ;
Zahm, Dirk M. ;
Holms, Frank ;
Glados, Manfred ;
Krabisch, Petra ;
Heck, Esther ;
Ober, Angelika ;
Lorenz, Petra ;
Diebold, Kurt ;
Habeck, Jorg-Olaf ;
Loib, Sibylle .
CLINICAL CANCER RESEARCH, 2016, 22 (23) :5747-5754
[16]   A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients [J].
Hwang, Hye Won ;
Jung, Hera ;
Hyeon, Jiyeon ;
Park, Yeon Hee ;
Ahn, Jin Seok ;
Im, Young-Hyuck ;
Nam, Seok Jin ;
Kim, Seok Won ;
Lee, Jeong Eon ;
Yu, Jong-Han ;
Lee, Se Kyung ;
Choi, Misun ;
Cho, Soo Youn ;
Cho, Eun Yoon .
BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (02) :255-266
[17]   Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer [J].
Jain, Parveen ;
Doval, Dinesh Chandra ;
Batra, Ullas ;
Goyal, Pankaj ;
Bothra, Sneha Jatan ;
Agarwal, Chaturbhuj ;
Choudhary, Dutta Kumardeep ;
Yadav, Abhishek ;
Koyalla, Venkata Pradeep Babu ;
Sharma, Mansi ;
Dash, Prashanta ;
Talwar, Vineet .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (04) :329-338
[18]  
James G, 2013, SPRINGER TEXTS STAT, V103, P303, DOI 10.1007/978-1-4614-7138-7_8
[19]   A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer [J].
Kantor, Olga ;
Sipsy, Lynn McNulty ;
Yao, Katharine ;
James, Ted A. .
ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (05) :1304-1311
[20]   Prognostic Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer [J].
Kim, Jee Ye ;
Park, Hyung Seok ;
Kim, Sanghwa ;
Ryu, Jegyu ;
Park, Seho ;
Kim, Seung Il .
MEDICINE, 2015, 94 (43)